(Q43856823)

27 November 2017

Distinctive multidrug sensitivity and outcome of acute erythroblastic and megakaryoblastic leukemia in children with Down syndrome (English)

1 reference

27 November 2017

1 reference

S Yamada

1

1 reference

27 November 2017

T Hongo

2

1 reference

27 November 2017

S Okada

3

1 reference

27 November 2017

C Watanabe

4

1 reference

27 November 2017

Y Fujii

5

1 reference

27 November 2017

H Hori

6

1 reference

27 November 2017

M Yazaki

7

1 reference

27 November 2017

R Hanada

8

1 reference

27 November 2017

Y Horikoshi

9

1 reference

27 November 2017

1 December 2001

1 reference

International Journal of Hematology

27 November 2017

1 reference

27 November 2017

74

1 reference

27 November 2017

4

1 reference

27 November 2017

428-436

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02982087

27 November 2017

0 references

cites work

Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02982087

Risks of leukaemia and solid tumours in individuals with Down's syndrome.

21 January 2018

1 reference

12 December 2020

Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group

1 reference

12 December 2020

Cellular drug resistance in acute myeloid leukemia: literature review and preliminary analysis of an ongoing collaborative study

1 reference

12 December 2020

Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891.

1 reference

12 December 2020

Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498

1 reference

12 December 2020

Down's syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction.

1 reference

12 December 2020

Myeloblasts from Down syndrome children with acute myeloid leukemia have increased in vitro sensitivity to cytosine arabinoside and daunorubicin

1 reference

12 December 2020

An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome.

1 reference

12 December 2020

Favorable treatment outcome in children with acute myeloid leukemia and Down syndrome

1 reference

12 December 2020

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

12 December 2020

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1 reference

12 December 2020

The treatment of children with acute megakaryoblastic leukemia who have Down syndrome

1 reference

12 December 2020

Neuronal cell death in Down's syndrome

1 reference

12 December 2020

In vitro chemosensitivity of lymphoblasts at relapse in childhood leukemia using the MTT assay

1 reference

12 December 2020

Molecular abnormalities of the brain in Down syndrome: relevance to Alzheimer's neurodegeneration

1 reference

12 December 2020

Interphase cytogenetic analysis of in vivo differentiation in the myelodysplasia of Down syndrome.

1 reference

12 December 2020

Improved outcome of acute myeloid leukaemia in Down's syndrome

1 reference

12 December 2020

An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia

1 reference

12 December 2020

Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia

1 reference

12 December 2020

Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin

1 reference

12 December 2020

In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, L-asparaginase, and vincristine in childhood acute lymphoblastic leukemia

1 reference

12 December 2020

A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Onco

1 reference

12 December 2020

Chromosome 7 abnormalities in children with Down syndrome and preleukemia

1 reference

12 December 2020

Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro.

1 reference

12 December 2020

Acute myelogenous leukemia in Down's syndrome: report of a single pediatric institution using a BFM treatment strategy

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02982087

1 reference

27 November 2017

1 reference